Clinical trial deaths rise in '12 drug makers say not at fault
Firms, foreign and Indian, reiterate they follow the rules fully earlier, SC had rapped govt for gaps in law and enforcement, including on compensation
Despite courts slamming the authorities over the monitoring of clinical trials in the country, the number of deaths caused by the adverse impact of drugs in these processes has risen. Data from the drug controller’s office, reviewed by Business Standard, show 12 drug-related deaths during clinical trials in the first eight months (till August) of 2012, as against 16 in all of 2011.